Genetic polymorphisms of the human MDR1 drug transporter

被引:234
作者
Schwab, M
Eichelbaum, M
Fromm, MF
机构
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany
[2] Univ Tubingen Hosp, Div Clin Pharmacol, D-72076 Tubingen, Germany
关键词
P-glycoprotein; ABC transporter; pharmacogenetics; drug disposition; pharmacogenomics;
D O I
10.1146/annurev.pharmtox.43.100901.140233
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P-glycoprotein is an ATP-dependent efflux pump that contributes to the protection of the body from environmental toxins. It transports a huge variety of structurally diverse compounds. P-glycoprotein is involved in limiting absorption of xenobiotics from the gut lumen, in protection of sensitive tissues (brain, fetus, testis), and in biliary and urinary excretion of its substrates. P-glycoprotein can be inhibited or induced by xenobiotics, thereby contributing to variable drug disposition and drug interactions. Recently, several SNPs have been identified in the MDR1 gene, some of which can affect P-glycoprotein expression and function. Potential implications of MDR1 polymorphisms for drug disposition, drug effects, and disease risk are discussed.
引用
收藏
页码:285 / 307
页数:23
相关论文
共 110 条
[1]   Structure and dynamics of the iron responsive element RNA: Implications for binding of the RNA by iron regulatory binding proteins [J].
Addess, KJ ;
Basilion, JP ;
Klausner, RD ;
Rouault, TA ;
Pardi, A .
JOURNAL OF MOLECULAR BIOLOGY, 1997, 274 (01) :72-83
[2]   Specificity of ribonucleoprotein interaction determined by RNA folding during complex formation [J].
Allain, FHT ;
Gubser, CC ;
Howe, PWA ;
Nagai, K ;
Neuhaus, D ;
Varani, G .
NATURE, 1996, 380 (6575) :646-650
[3]   Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers [J].
Alsenz, J ;
Steffen, H ;
Alex, R .
PHARMACEUTICAL RESEARCH, 1998, 15 (03) :423-428
[4]   Biochemical, cellular, and pharmacological aspects of the multidrug transporter [J].
Ambudkar, SV ;
Dey, S ;
Hrycyna, CA ;
Ramachandra, M ;
Pastan, I ;
Gottesman, MM .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 :361-398
[5]   MDR1 pharmacogenetics:: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity [J].
Ameyaw, MM ;
Regateiro, F ;
Li, T ;
Liu, XH ;
Tariq, M ;
Mobarek, A ;
Thornton, N ;
Folayan, GO ;
Githang'a, J ;
Indalo, A ;
Ofori-Adjei, D ;
Price-Evans, DA ;
McLeod, HL .
PHARMACOGENETICS, 2001, 11 (03) :217-221
[6]   Racial variation in dosage requirements of tacrolimus [J].
Andrews, PA ;
Sen, M ;
Chang, RWS .
LANCET, 1996, 348 (9039) :1446-1446
[7]   Role of transport proteins in drug absorption, distribution and excretion [J].
Ayrton, A ;
Morgan, P .
XENOBIOTICA, 2001, 31 (8-9) :469-497
[8]   The blood-brain barrier and oncology: new insights into function and modulation [J].
Bart, J ;
Groen, HJM ;
Hendrikse, NH ;
van der Graaf, WTA ;
Vaalburg, W ;
de Vries, EGE .
CANCER TREATMENT REVIEWS, 2000, 26 (06) :449-462
[9]   The drug efflux-metabolism alliance: biochemical aspects [J].
Benet, LZ ;
Cummins, CL .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 50 :S3-S11
[10]   Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects [J].
Cascorbi, I ;
Gerloff, T ;
Johne, A ;
Meisel, C ;
Hoffmeyer, S ;
Schwab, M ;
Schaeffeler, E ;
Eichelbaum, M ;
Brinkmann, U ;
Roots, I .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :169-174